Sep. 1 at 9:22 AM
$PFE Both Pfizer (NYSE:PFE) and Starbucks (NASDAQ:SBUX) raised or improved their forward outlooks this summer, which is the clearest evidence a recovery is genuine. The question for income-focused investors right now is which one belongs in a portfolio that has to fund withdrawals, not just chase upside. The tiebreaker is what each pays a holder to wait and how far along each turnaround actually is.